Cargando…

Bufei Decoction Alleviated Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Mice by Anti-Inflammation

OBJECTIVE: This study aimed to investigate the mechanistic action and therapeutic effects of Bufei decoction on idiopathic pulmonary fibrosis (IPF) after inhalation of bleomycin. METHODS: Pulmonary fibrosis model in mice was prepared by atomization inhalation of bleomycin. Then, the mice were random...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shanjun, Cui, Wenwen, Wang, Mingye, Xing, Luming, Wang, Yue, Zhu, Pengyu, Qu, Qisheng, Tang, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495219/ https://www.ncbi.nlm.nih.gov/pubmed/32963571 http://dx.doi.org/10.1155/2020/7483278

Ejemplares similares

Yiqi Huayu decoction alleviates bleomycin-induced pulmonary fibrosis in rats by inhibiting senescence
por: Zuo, Biao, et al.
Publicado: (2022)

Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma
por: Park, Gyu-Tae, et al.
Publicado: (2021)

Maiwei Yangfei decoction prevents bleomycin-induced pulmonary fibrosis in mice
por: Xu, Yong, et al.
Publicado: (2021)

Jinlian Xiaodu Decoction Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats
por: Wu, Zhiqiang, et al.
Publicado: (2022)

Metabolomics unveils the mechanism of Bufei Huayu decoction in combination with cisplatin against non-small cell lung cancer (NSCLC)
por: Feng, Yuan, et al.
Publicado: (2023)

Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model
por: Pei, Zhuo, et al.
Publicado: (2022)

Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats
por: Gao, Lili, et al.
Publicado: (2015)

Bufei Decoction Improves Lung-Qi Deficiency Syndrome of Chronic Obstructive Pulmonary Disease in Rats by Regulating the Balance of Th17/Treg Cells
por: Shen, Junxi, et al.
Publicado: (2022)

Bufei Huoxue Capsule Attenuates PM2.5-Induced Pulmonary Inflammation in Mice
por: Jing, Yue, et al.
Publicado: (2017)

Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice
por: Fu, Qiang, et al.
Publicado: (2017)

ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model
por: Cao, Dianyu, et al.
Publicado: (2023)

Buyang Huanwu Decoction Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats via Downregulation of Related Protein and Gene Expression
por: Wang, Xuan, et al.
Publicado: (2018)

Pharmacokinetics and tissue distribution of bleomycin-induced idiopathic pulmonary fibrosis rats treated with cryptotanshinone
por: He, Xiangjun, et al.
Publicado: (2023)

Dose-response Effects of Bleomycin on Inflammation and Pulmonary Fibrosis in Mice
por: Kim, Soo Nam, et al.
Publicado: (2010)

Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Paeonol
por: Liu, Meng-Han, et al.
Publicado: (2017)

Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Bilobalide
por: Zhang, Xingcai, et al.
Publicado: (2023)

Acute exacerbation of idiopathic pulmonary fibrosis model in the rats using bleomycin and lipopolysaccharides
por: Kurniawan, Sandy Vitria, et al.
Publicado: (2023)

Macrophage‐based delivery of anti‐fibrotic proteins alleviates bleomycin‐induced pulmonary fibrosis in mice
por: Liu, Huiying, et al.
Publicado: (2023)

Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis
por: Mou, Fanghong, et al.
Publicado: (2020)

Gefitinib Inhibits Bleomycin-Induced Pulmonary Fibrosis via Alleviating the Oxidative Damage in Mice
por: Li, Li, et al.
Publicado: (2018)

A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis
por: Kasamatsu, Hiroshi, et al.
Publicado: (2023)

Bu-Fei-Huo-Xue capsule alleviates bleomycin-induced pulmonary fibrosis in mice through modulating gut microbiota
por: Hu, Haibo, et al.
Publicado: (2023)

Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury
por: Cui, Wenwen, et al.
Publicado: (2021)

The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis
por: Kulkarni, Ajit A., et al.
Publicado: (2013)

Pharmacological effects of Bufei Jianpi granule on chronic obstructive pulmonary disease and its metabolism in rats
por: Yang, Xin-Xin, et al.
Publicado: (2022)

Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression
por: Wang, Weimin, et al.
Publicado: (2023)

Fisetin Alleviated Bleomycin-Induced Pulmonary Fibrosis Partly by Rescuing Alveolar Epithelial Cells From Senescence
por: Zhang, Li, et al.
Publicado: (2020)

Megakaryocytes participate in the occurrence of bleomycin-induced pulmonary fibrosis
por: Zhou, Yan, et al.
Publicado: (2019)

IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation
por: Dong, Zhaoxing, et al.
Publicado: (2015)

Jiaweishaoyao Decoction Alleviates DSS-Induced Ulcerative Colitis via Inhibiting Inflammation
por: Qiao, Huixia, et al.
Publicado: (2020)

Rac2 is involved in bleomycin-induced lung inflammation leading to pulmonary fibrosis
por: Arizmendi, Narcy, et al.
Publicado: (2014)

Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo
por: Huang, Tsung-Teng, et al.
Publicado: (2015)

Prostaglandin D(2) Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis
por: Kida, Taiki, et al.
Publicado: (2016)

The IL-33 Receptor ST2 Regulates Pulmonary Inflammation and Fibrosis to Bleomycin
por: Fanny, Manoussa, et al.
Publicado: (2018)

Resveratrol alleviates bleomycin-induced pulmonary fibrosis via suppressing HIF-1α and NF-κB expression
por: Wang, Zaiyan, et al.
Publicado: (2021)

Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis
por: Tong, Bin, et al.
Publicado: (2021)

Jinbei Oral Liquid ameliorates bleomycin-induced idiopathic pulmonary fibrosis in rats via reversion of Th1/Th2 shift
por: Xing, Xiao-yan, et al.
Publicado: (2020)

Spred2-deficiency enhances the proliferation of lung epithelial cells and alleviates pulmonary fibrosis induced by bleomycin
por: Kawara, Akina, et al.
Publicado: (2020)

Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
por: Ishida, Yuko, et al.
Publicado: (2023)

HIP/PAP protects against bleomycin‐induced lung injury and inflammation and subsequent fibrosis in mice
por: Zheng, Xiaoyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n3ra9klqvvcgh0rdlv2nj1k01a